Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Capital Leases (2024 - 2025)

Historic Capital Leases for Exagen (XGN) over the last 2 years, with Q3 2025 value amounting to $2.1 million.

  • Exagen's Capital Leases changed N/A to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year change of. This contributed to the annual value of $157000.0 for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Exagen's Capital Leases stood at $2.1 million.
  • Over the past 5 years, Exagen's Capital Leases peaked at $2.1 million during Q3 2025, and registered a low of $157000.0 during Q4 2024.